News and Events
2012
The death of Harry W. Hind, who prompted Teikoku to develop Lidoderm®, was announced today on the website of the San Francisco Chronicle
May 2, 2012
Harry W. Hind, a San Francisco pharmacist, inventor and bodysurfer, just had a way of looking at something and seeing how it could be improved. No problem could not be solved, said his friends and family members...
READ MORE2011
Teikoku Pharma USA (TPU) announced that its wholly owned subsidiary, Travanti Pharma in Mendota Heights, MN, has been merged into TPU
September 30, 2011
Teikoku Pharma USA (TPU)announced that its wholly owned subsidiary, Travanti Pharma in Mendota Heights, MN, has been merged into TPU. Prior to the merger, Travanti Pharma sold its IontoPatch® business to The Tapemark Company in West St. Paul, MN, which will continue the business and market it under the Travanti Medical brand.
READ MORETeikoku Pharma USA, Inc. and Verde Environmental Technologies announce Licensing Agreement for Pharmaceutical Disposal Technology
September 14, 2011
Teikoku Pharma USA, Inc., (“TPU”) is pleased to announce an exclusive license agreement with Verde Environmental Technologies Inc., (“Verde”) a company aimed at developing environmentally responsible solutions for pharmaceutical disposal.
READ MORETapemark Acquiring Iontophoretic Technology
September 2, 2011
Tapemark has agreed to acquire the iontoPatch business from Travanti Pharma Inc., a wholly owned subsidiary of Teikoku Pharma USA Inc.
READ MORE2010
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review
September 17, 2010
Teikoku Pharma USA, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept®, a leading medication for the treatment of Alzheimer’s disease.
READ MORE